Intrinsic Value of S&P & Nasdaq Contact Us

Longeveron Inc. LGVN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+792.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Longeveron Inc. (LGVN) has a negative trailing P/E of -1.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 0.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -88.41%, forward earnings yield 192.31%. PEG 0.01 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.01); analyst target implies upside (+792.9%).
  • Forward P/E 0.5 — analysts expect a return to profitability with estimated EPS of $2.15 for FY2029.
  • PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -88.41% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 192.31% as earnings recover.
  • Analyst consensus target $10.00 (+792.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 56/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
50/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — LGVN

Valuation Multiples
P/E (TTM)-1.1
Forward P/E0.5
PEG Ratio0.01
Forward PEG0.01
P/B Ratio4.53
P/S Ratio21.77
EV/EBITDA-1.0
Per Share Data
EPS (TTM)$-0.99
Forward EPS (Est.)$2.15
Book Value / Share$0.25
Revenue / Share$0.05
FCF / Share$-0.83
Yields & Fair Value
Earnings Yield-88.41%
Forward Earnings Yield192.31%
Dividend Yield0.00%
Analyst Target$10.00 (+792.9%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2018 -18.6 0.00 17.30 55.21 -
2019 -31.9 0.60 26.70 21.08 -
2020 -33.6 -1.85 63.84 22.20 -
2021 -13.4 -0.04 6.10 174.81 -
2022 -3.6 0.00 3.29 55.25 -
2023 -1.4 -0.10 4.39 41.69 -
2024 -1.6 0.02 1.18 10.77 33.58%
2025 -0.4 -0.02 1.57 7.42 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2018 $-3.98 $2.13M $-6.34M -296.8%
2019 $-1.87 $5.64M $-3M -53.1%
2020 $-2.25 $5.63M $-3.79M -67.3%
2021 $-9.07 $1.31M $-17.16M -1314.2%
2022 $-9.36 $1.22M $-19.63M -1606.1%
2023 $-9.85 $709K $-21.41M -3020.2%
2024 $-1.07 $2.39M $-15.97M -667.8%
2025 $-1.29 $1.2M $-22.7M -1893.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.62 $-0.82 – $-0.40 $750K $210.43K – $1.29M 1
2027 $-0.62 $-0.97 – $-0.27 $834K $556K – $1.11M 2
2028 $-0.86 $-2.84 – $1.12 $2.9M $374.96K – $7.14M 2
2029 $2.15 $-0.28 – $6.24 $216.31M $28.02M – $533.12M 1
2030 $3.30 $-0.43 – $9.58 $308.61M $39.97M – $760.61M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message